Hit enter to search or ESC to close
As a blogger, I've been researching the differences between Atenolol and other beta-blockers. What sets Atenolol apart is its selectivity for beta-1 receptors, which mainly affects the heart rather than other areas of the body. This makes it less likely to cause side effects like bronchoconstriction, which can be a problem with non-selective beta-blockers. Additionally, Atenolol has a longer half-life, meaning it can be taken once a day for better patient compliance. Overall, Atenolol appears to be a more targeted option with fewer side effects compared to other beta-blockers on the market.
View More